A human ESC line for efficient CRISPR editing of pluripotent stem cells

Human pluripotent stem cells (hPSC) can be directed to differentiate in vitro into insulin-prorducing beta cells (SC-β). Although these cells accurately respond to glucose and can reverse diabetes in preclinical models improvments in the final cell products are desirable. For example, safety, contro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elad Sintov, Dario Gerace, Douglas A. Melton
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/c13124af03dd436c9fac4750b2a61845
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!